GlassScriptPhysician profile
Anthony J Lamarra
NPI 1447388285
$3,665.21
in general payments reported to CMS, 2019-2025
15 companies · $33.87 in 2025
The $33.87 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $275 · 2020: $327 · 2021: $40.45 · 2022: $66.81 · 2023: $2,808 · 2024: $113 · 2025: $33.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $2,495 · Food and Beverage: $460.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $2,495.00 |
| Food and Beverage | $460.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| International Rehabilitative Sciences, INC | $2,514.12 | 2023 | Rs 4i Plus Sequential Stimulator |
| Stryker Corporation | $544.45 | 2019-2025 | Augment Injectable, Flexband Plus |
| Musculoskeletal Transplant Foundation INC. | $255.64 | 2020 | |
| Treace Medical Concepts, INC. | $86.35 | 2022-2023 | |
| Zimmer Biomet Holdings, INC. | $42.45 | 2019 | |
| Lifenet Health | $34.96 | 2024 | Theragenesis Wound Matrix |
| Paratek Pharmaceuticals, INC. | $34.12 | 2024 | Nuzyra |
| Kowa Pharmaceuticals America, INC. | $30.27 | 2022 | |
| Triad Life Sciences INC. | $23.78 | 2022 | |
| Abbott Laboratories | $23.01 | 2023 | Eterna |
| Allergan, INC. | $19.41 | 2020 | |
| Abbvie INC. | $17.69 | 2021 | |
| Medtronic, INC. | $16.20 | 2023 | Intellis Adaptivestim |
| Extremity Medical | $11.87 | 2021 | |
| Kerecis Limited | $10.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Lamarra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.